Retinoic acid for treatment of multicentric Castleman's disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10520638.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Multicentric Castleman's syndrome has an aggressive course with poor prognosis, and its treatment remains uncertain. We report a woman with multicentric Castleman's disease that was successfully treated with prednisone and retinoic acid.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Castleman Disease
- Prednisone
- Tretinoin